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CytologyAbstract Introduction: The main role of ﬁne needle aspiration cytology (FNAC) lies in differen-
tiating between a malignant and benign thyroid nodule. It greatly inﬂuences the treatment decision.
The current study was undertaken to evaluate the cytology–histopathology correlation and to
analyze the cause of diagnostic errors with an eventual aim to improve diagnostic accuracy.
Materials and Methods: This is a retrospective study comparing cytology and corresponding
histopathology report in 724 thyroid cases. The statistical analysis included false positive rate, false
negative rate, sensitivity, speciﬁcity, positive predictive value, negative predictive value and accuracy.
Results: On cytological examination, 635/724 were reported as benign, 68 malignant and 21 suspi-
cious. On histopathological examination, 626/635 cases were conﬁrmed as benign but there were 9
discordant cases. Among the other cases histopathology diagnosis of malignancy matched in
66/68 and 11/21 cases. Diagnosis correlated in 703/724 cases (97%) [p< 0.001].
False positive and false negative rates were 1.9% and 10.5%, respectively. The sensitivity and
speciﬁcity were 89.5% and 98%, respectively. The positive predictive value was 84.6% and negative
predictive value was 98.6%. Accuracy of FNA was 97%.
Conclusion: In spite of high accuracy of FNAC in differentiating between a benign and malignant
lesion, certain pitfalls should be kept in mind. The common false negative diagnoses were follicular
pattern cases which constitute a ‘gray zone’, cystic papillary thyroid carcinoma (PTC) and papillary
microcarcinoma. The reason for false positive diagnoses was the occurrence of nuclear features char-
acteristic of PTC in other thyroid lesions. Awareness of pathologist regarding these pitfalls can min-
imize false negative/positive diagnoses.
ª 2015 The Author. Production and hosting by Elsevier B.V. on behalf of National Cancer Institute,
Cairo University. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Thyroid Fine Needle Aspiration Cytology (FNAC) was intro-
duced in Scandinavian countries in 1950s and became popular
in the United States in 1970s and then worldwide in the 1980s
148 C. Sharma[1] Today it remains the mainstay of diagnostic workup for
thyroid pathologies. Thyroid FNA is a safe and relatively sim-
ple test that is widely recognized as the critical, primary diag-
nostic procedure of ﬁrst choice for the evaluation of patients
presenting with thyroid nodules [2–7]. One of the major
advantages is that FNAC can be done as an out-patient
procedure.
Thyroid nodules are a common clinical ﬁnding and have a
reported prevalence of 4–7% in the general population [2,8,9].
The vast majority of these nodules are non-neoplastic lesions
or benign neoplasms. FNAC is relied upon to distinguish
benign from neoplastic or malignant thyroid nodules and
therefore has lead to a dramatic decrease in thyroid surgeries
[10]. Nevertheless, Fine needle Aspiration has some limitations
like specimen inadequacy, sampling techniques and WHAFFT
changes [11–14]. Cytopathologist should be aware of these
potential limitations and pitfalls of FNA interpretation.
The present study was performed with the aim to evaluate
the value of FNA in differentiating benign and malignant
lesions of thyroid. Our another aim was to analyze the false
positive and false negative diagnosis so as to highlight the pit-
falls of FNA and probable reasons for the same are discussed.
We hope that a better understanding of these pitfalls would
help avoiding them in future and will contribute to better
patient care.
Materials and methods
This is a retrospective review of all thyroid FNAs done at our
institution between January 2010 and December 2014. Data
were retrieved from the institutional database and analyzed.
There were 945 thyroid FNAs done during this period.
Ultrasound guided FNAs at our institution are very infrequent
and most of the FNAs in the present study were without
ultrasound guidance. This cytological study was based on
evaluation of FNA smears. In patients with multiple nodules,
even if one nodule was malignant and the other benign it was
reported as malignant in cytology and considered in the
malignant category.
Cytological diagnosis of thyroid lesions at our institution is
inﬂuenced by the guidelines of Royal college of Pathologists
[15]. The cytological results were categorized into 5 categories:
unsatisfactory; benign; follicular pattern lesions; suspicious
(includes atypical) and malignant.
Samples were considered ‘‘unsatisfactory’’ if there was
insufﬁcient cellularity; cellularity was obscured by blood, poor
quality smears or delayed/inadequate ﬁxation. For cystic
lesions, smears with insufﬁcient cellularity i.e. if there were less
than six groups of thyroid follicular epithelial cells across all
the submitted slides, each with at least 10 well visualized
epithelial cells and which contain mostly macrophages but
without abundant colloid were included in the unsatisfactory
category [15].
Cystic lesions which were not unsatisfactory by the above
deﬁnition were considered satisfactory and considered for this
correlation study. As per the Royal College guidelines [15],
these include:
 Cystic lesion ﬂuid samples which have sufﬁcient thyroid
follicle cells to achieve the adequacy criterion, irrespective
of any possible colloid and/or macrophage content Cystic lesion specimens which consist predominantly of col-
loid and macrophages, even if too few follicular epithelial
cells are present to meet the adequacy criteria outlined
above, can be considered to be ‘consistent with a colloid
cyst’ in the appropriate clinical setting.
At our institute, all the cystic lesions with ‘atypia’ are
reported as ‘‘suspicious’’ of malignancy. As this paper was
speciﬁcally aimed to ﬁnd out the efﬁcacy of FNA in ruling
out malignancy; to keep the comparisons clear we have
included all the cysts without atypia in the benign category
and those reported as ‘‘suspicious’’ in malignant category.
‘Follicular pattern lesion’ forms a ‘gray zone’ in cytology
and it is difﬁcult to rule out malignancy on cytology in these
lesions [16,17] We report these lesions as ‘follicular pattern
lesions’ and advice excision of the lesion followed by HPE
for conﬁrmation.
If atypical cells are seen it is mentioned additionally in the
report to provide a clear picture to the surgeon. For the pur-
pose of this study the follicular pattern lesions with atypical
cells are classiﬁed in ‘suspicious category’ as they are managed
is the same way i.e. surgical excision and HPE. In follicular
pattern lesions without atypia clinical judgment should play
a large role in deciding to watch, repeat FNA or even excise
in certain circumstances. Since there was no evidence of malig-
nancy on cytology in these cases we have grouped them in
benign category for this study.
As the present study aims to correlate the accuracy of the
FNA in detecting the malignant/benign lesions on cytology
the follicular lesions without atypia were categorized as benign
and follicular lesions with atypia as ‘suspicious’. Suspicious
lesions have been clubbed with malignant ones as both are
treated as same as far as treatment is concerned. Such lesions
are advised surgery followed by histopathological examination
for deﬁnite diagnosis.
The corresponding histopathology report was available for
724 cases. The patients who underwent either of the two tests
in any other institution were excluded from the study. The
FNA samples which were inadequate for evaluation were also
excluded. A total of 724 cases who had both cytology and
histopathology reports available formed the study group to
analyze the value of FNA in thyroid pathologies. The
statistical analysis included false positive rate, false negative
rate, sensitivity, speciﬁcity, positive predictive value, negative
predictive value and accuracy.
Results
945 thyroid FNAs were done in our institute between 2010 and
2014. Most of the patients were in the age group 30–50 years
(Fig. 1). There were 82% female and 18% male patients
(Fig. 2). Out of these 945 cases, the FNA sample was adequate
in 870 cases. Histopathology correlation was available for 724
cases, which formed the study population. Among the 724
cases 635 (87.7%) were reported as benign on cytology and
the diagnosis were as follows: 324 (44.8%) cases were nodular
goiter, 232 (32.0%) were Hashimoto’s thyroiditis, 48 (6.6%)
were follicular lesions and 44 (6.0%) were cystic lesions of thy-
roid (Fig. 3). 68 cases out of 724 were diagnosed as malignant
on cytology. Of these, 62 (8.6%) cases were reported as PTC
and 6 (0.8%) as medullary carcinoma (Fig. 3). 21 (2.90%)
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Table 1 Cyto-histopathology correlation of all the cases.
Cytological
diagnosis
Histopathology
diagnosis
Discordant
cases
Benign (N= 635) Benign (N= 626) 9
[TN] [FN]
Malignant (N= 68) Malignant (N= 66) 2
[TP] [FP]
Suspicious (N= 21) Malignant (N= 11) 10*
[TP] [FP]
Benign (N= 10)
TN – True Negative; FN – False Negative; TP – True Positive;
FP – False Positive.
* The suspicious cases were included in the malignant category
for statistical analysis as such cases are usually treated by clinicians
as malignancies.
Table 2 Details of the discordant cases.
Discordant
cases (No.)
Cytological
diagnosis
Histopathology diagnosis
9 Benign Malignant
(3-FVPTC; 2-Conventional PTC;
2-Cystic PTC; 1-Follicular Carcinoma;
1-Hashimoto’s with papillary
microcarcinoma)
2 Malignant
(PTC)
Benign
(2-Nodular Goiter)
10 Suspicious Benign
(7-Nodular Goiter; 2-Follicular
adenoma; 1-Hashimoto’s thyroiditis)
Total = 21
Diagnostic Accuracy of FNAC of Thyroid 149out of 724 cases were in the suspicious/atypical cells category,
where a possibility of malignancy was suggested and surgical
excision was advised for a deﬁnite diagnosis (Fig. 3).
HPE of 635 benign cytology cases revealed 626 cases as
benign and 9 cases as malignant (Table 1). The HP diagnosis
for these 9 cases was as follows: 3 FVPTC, 2 conventional
PTC, 2 cystic PTC, 1 follicular carcinoma and 1 Hashimoto’s
thyroiditis with papillary microcarcinoma (Table 2). Out of
62 cases with a FNA diagnosis of PTC, 60 proved to be the
same on HPE but the HP diagnosis differed in 2 cases and
was that of nodular goiter (Tables 1 and 2). The cytology diag-
nosis correlated with HP diagnosis for all 6 medullary carcino-
mas. Out of the 21 suspicious/atypical cases almost half of the
cases i.e. 11 cases were malignant on HPE, but, 10 cases came
out to be benign contrary to the cytological diagnosis
(Table 1). 5 out of the 11 malignant cases were conventional
PTC and 6 were follicular variant of PTC. Among the 10
benign cases, 7 were nodular goiter or adenomatous goiter, 2
were follicular adenomas and 1 case was Hashimoto’s
thyroiditis (Table 2).Statistical analysis was done to ﬁnd out the value of FNA
in detecting malignancy in thyroid swellings.
Statistical analysis included
 Sensitivity (probability that a test result will be positive
when the disease is present – ‘true positive
rate’)Sensitivity = True positive/(True positive + False
negative) = 77/(77 + 9) = 89.5%
 Speciﬁcity (probability that a test result will be negative
when the disease is not present – ‘true negative
rate’)Speciﬁcity = True negative/(True negative + False
positive) = 626/(626 + 12) = 98%
 Positive predictive value (probability that the disease is pre-
sent when the test is positive)Positive predictive value
(PPV) =True positive/(True positive + False positive) =
66/(66 + 12) = 84.6%
 Negative predictive value (probability that the disease is not
present when the test is negative)Negative predictive value
(NPV) =True negative/(True negative + False negative) =
626/(626 + 9) = 98.6%
 False positive rate = False positive/(False positive + True
negative) = 12/(12 + 626) = 1.9%
 False negative rate = False negative/(False negative +
True positive) = 9/(9 + 77) = 10.5%
 Accuracy is the portion of the correct results, true
positive and true negative in relation to all cases
150 C. Sharmastudied.Accuracy = True positive + True negative/Total
number of cases = 77 + 626/724 = 97%.
To summarize the results: False positive rate was 1.9% and
false negative rate was 10.5%. The sensitivity and speciﬁcity
were 89.5% and 98% respectively. The positive predictive
value was 84.6% and negative predictive value was 98.6%.
Accuracy of FNA in differentiating benign from malignant
thyroid lesion was 97%.Discussion
Fine needle aspiration cytology (FNAC) is regarded as a gold
standard in the initial diagnosis of thyroid nodules. It is simple,
reliable, time saving, minimally invasive and cost effective
[1–7]. However there are some limitations of FNAC which a
pathologist must be aware of [11–14]. The main information
one wants from FNAC is to distinguish a malignant lesion
from a benign one. This distinction has dramatically reduced
the surgery rates in thyroid pathologies [10]. Though the
accuracy rates as high as 95–98% have been reported in best
hands FNAC has some limitations, and false positive and false
negative results do occur [3,5].
The reporting systems for thyroid cytology vary among
institutions and include 4 category system [2], 5 category
system [15] or 6 category systems [18]. The most widely used
ones are the Bethesda system [18] (6 category) and the Royal
College of Pathologist [15] (5 category) system.
The Royal College of Pathologists thyroid ﬁne-needle aspi-
ration diagnostic classiﬁcation is a robust tool for the clinical
management of abnormal thyroid nodules with established
reproducibility [19,20]. Cytological diagnosis of thyroid lesions
at our institution is inﬂuenced by the guidelines of Royal col-
lege of Pathologists. Use of terminologies like – undetermined
signiﬁcance, atypical leads to confusion for the clinicians and
are avoided at our institution. We categorize lesions as, unsat-
isfactory; benign; follicular pattern lesions; suspicious
(includes atypical) and malignant.
The current study was undertaken to evaluate the correla-
tion between cytology and histology in thyroid FNA in our
institute and to analyze the cause of the diagnostic errors with
an eventual aim to improve accuracy. It is of utmost impor-
tance because the treatment is greatly inﬂuenced by the
FNAC report. The surgical rate for benign nodules in our study
is much higher because our institution is a surgical referral cen-
ter and most of the patients are referred to the hospital for sur-
gical intervention. Most of the patients would have had initial
workup at the primary hospital and referred for surgical inter-
vention to our surgical team and FNAs are done to reassess the
diagnosis at our institution before surgical intervention.
As FNAC is mainly aimed to rule out malignancy it should
have a low false-negative rate, acceptable sensitivity and speci-
ﬁcity for detection of malignancy and high negative predictive
value. The reported sensitivity of thyroid FNA ranges from
65% to 99% and its speciﬁcity from 72% to 100% [10,21–25].
In addition, there are some studies in the literature reporting
sensitivity as low as 55.3% and false negative as low as 44.7%
[26]. The likely reasons reported for lower sensitivity in
series of Mistry et al. were combination of operator variability,
low number (56 cases) and diagnostic difﬁculty of usingFNAC in certain thyroid pathologies [26]. This shows that
there is signiﬁcant disparity in reported thyroid FNAC statis-
tics [27]. The determinant factors for wide range of difference
could be number of cases, the included diagnostic categories
and how the cytopathologist classiﬁes the suspicious lesions
[28].
There is disparity in the literature in the way the cystic
lesions are categorized; some categorize all the cystic lesions
in unsatisfactory category whereas others do not [2,15]. In
our institution, hypocellular aspirates in the presence of cystic
ﬂuid are not considered to be non-diagnostic because in these
cases the presence of no or a few cells is correlated with the
structure of the nodule itself and not with an inadequate sam-
pling technique. We agree with the Royal College guidelines
[15] and follow them in our institution because for such lesions
if they are labeled as ‘‘unsatisfactory’’ it could imply that the
material is not appropriate. In such lesions even a repeat sam-
ple would be ‘‘unsatisfactory’’. Hence, it is more appropriate
to not include them in ‘‘unsatisfactory’’ category.
All the cystic lesions with ‘atypia’ were reported as ‘‘suspi-
cious’’ of malignancy. This is in accordance with the work
published by Ravetto where specimens were diagnosed as ‘‘sus-
picious’’ when cells showed atypical features suggestive of, but
not diagnostic for, malignancy [7]. As our study speciﬁcally
aimed to ﬁnd out the efﬁcacy of FNA in ruling out malig-
nancy; we have included all the cysts without atypia in the
benign category and those reported as ‘‘suspicious’’ in malig-
nant category. Distribution of the cysts into either a benign
or those with ‘atypia’ in malignant category allowed easier
comparison and clearer outcome.
In the present study the cases reported as ‘suspicious’ on
cytology were included in the malignant category for statistical
analysis because both lead to surgical management as far as
the treatment is concerned [27]. This allows for an easier com-
parison and clearer ﬁnal results.
In our study the sensitivity of FNAC was 89.5% and speci-
ﬁcity was 98%. This indicated that ability of FNA to detect
malignancy in our series was quite high. The comparable stud-
ies in literature report sensitivity in the range of 82–93.4% and
speciﬁcity of 74.9–96% [2,7,11,12,21,28,29].
The positive predictive value in our series was 84.6% com-
pared to 85.7–98.6% in other studies [11,28,29]. The negative
predictive value in our series was 98.6% as compared to
91.8–94% in similar studies in literature [12,28,29]. The accu-
racy of FNA in detecting malignancy in thyroid lesions in
our study was 97% which reinforces that FNAC can be used
as a reliable tool to detect thyroid malignancy. Other studies
in the literature report accuracy ranging from 83.6% to
93.6% and support our results [12,28,29].
The reported false-negative rate ranges from 1% to 19%
[10,22,25,28,30–32]. However, it is difﬁcult to know the true fre-
quency of false-negative results because only a small percentage
(approximately 10%) of patients with benign cytologic ﬁndings
undergo surgery [10,25]. It has been postulated that the true
false-negative rate is below 5% if all patients with thyroid
FNA also have a histologic examination [25]. In our study false
negative rate was 10.5%. Our false-negative rate is in the higher
side of reported range in literature probably because of the same
fact. Also, this reﬂects the limitation of FNAC in accurately
diagnosing follicular pattern lesions, cystic papillary thyroid
carcinoma (PTC) and papillary microcarcinoma.
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(nodular goiter), follicular neoplasm (follicular adenoma and
carcinoma) and follicular variant of PTC. Use of various
terms, including ‘‘atypical,’’ indeterminate, favor, cannot
exclude, possible, or probable and suspicious by pathologists
often creates confusion for the clinicians [33]. It is truly a gray
zone in thyroid cytology [16,17]. We report these lesions as
‘follicular pattern lesions’ and advice excision of the lesion fol-
lowed by HPE for conﬁrmation.
As the present study is to correlate the accuracy of the FNA
in detecting the malignant/benign lesions on cytology the fol-
licular lesions without atypia were categorized as benign and
follicular lesions with atypia as ‘suspicious’. Suspicious lesions
have been clubbed with malignant ones as both are treated as
same as far as treatment is concerned.
Our practice regarding use of the category ‘‘atypical’’ is
similar to MMC (Monteﬁore Medical Center (MMC) [33]
and includes all potentially neoplastic follicular lesions that
do not show overt papillary features with the expectation that
these patients will be offered a hemithyroidectomy in the
appropriate clinical setting. These lesions in our study are
included in the ‘suspicious category’ as this indicates the need
for surgery and conﬁrmation by HPE.
Studies in the past have highlighted the fact that in follicu-
lar variant of papillary thyroid carcinoma (FVPTC), the
nuclear features essential for a cytologic diagnosis of PTC
are infrequent [34–37] and sensitivity of FNA in establishing
a diagnosis of FVPTC is low [38]. These concerns in the liter-
ature are further afﬁrmed in our observation study where
FVPTC cases accounted for 3 of the 9 discordant cases with
benign cytology. Even the presence of infrequent nuclear fea-
tures of PTC should alarm the pathologist to consider the
diagnosis of FVPTC which is a major diagnostic challenge.
As FNA is considered a screening procedure, particular atten-
tion should be given to minimizing false-negative diagnoses,
even at the expense of accepting false-positive diagnoses [39].
False negative diagnosis can also occur due to inadequate
sampling or due to aspiration of ﬂuid from cystic lesions of
thyroid with an underlying malignancy. This could be the rea-
son for another two false negative cases (out of 9 discordant
cases with benign cytology) in our series (Table 2). Among
all the thyroid cancers, PTC tends to undergo marked hemor-
rhagic degenerative changes. Sampling of this hemorrhagic
ﬂuid with sparse tumor cells may result in false interpretation
as a benign cyst [40]. In these two cases, suggestion for surgical
excision had been given by the pathologist in order to rule out
an underlying malignancy, which led to timely surgery and
saved the patient of undue complications of PTC.
Although, ﬁne-needle biopsy is the best predictor of malig-
nancy in either cystic or solid thyroid lesions, it is slightly less
reliable when a thyroid lesion is ﬂuid ﬁlled rather than solid
[41]. A close follow up or thyroid lobectomy for diagnosis
should be strongly considered in these patients even when
FNA cytologic ﬁnding is interpreted as benign [42,43].
Careful attention to details of the procurement process will
have a signiﬁcant impact on both inadequacy and false-
negative rates. Meticulous examination of all the smears is of
paramount importance in reducing discrepant cases [44]. Any
recurrent cystic lesion should raise a strong suspicion for
malignancy and should be treated so.
One of the other false negative cases (out of total 9) was
reported as Hashimoto’s thyroiditis on cytology. This caseon HPE was found to be papillary microcarcinoma of thyroid.
The term papillary microcarcinoma is used when the papillary
carcinoma is an incidental ﬁnding and measures less than one
centimeter in diameter. Papillary microcarcinoma arising in
Hashimoto’s thyroiditis or in any other benign lesion has high
chances of being missed because FNAC is mostly done as a
blind procedure and as a result of which the aspirated sample
may not be fully representative of the existing lesion. Papillary
microcarcinomas of the thyroid (i.e. papillary carcinomas
<1 cm in size) are frequent; autopsy surveys have revealed
prevalence of up to 30% in high risk groups [45]. However,
their clinical impact is limited in the vast majority of cases
and do not cause a signiﬁcant reduction in survival [7].
One another false negative case which was reported as fol-
licular lesion on FNA turned out to be follicular carcinoma.
This is one of the pitfalls of FNA, as FNA cannot distinguish
benign follicular nodules from follicular carcinomas because
the criteria to distinguish between them are based upon histo-
logic evidence of transcapsular or vascular invasion which can-
not be assessed on cytology [46].
The false positive rate reported in the literature range from
6% to 8% [10,27,28]. In our study the rate is very low (1.9%).
Out of our 12 cases of false positive diagnosis, six were diag-
nosed as PTC or suspicious of PTC on FNA. The HP diagno-
sis of these cases was adenomatous goiter in 5 cases and
Hashimoto’s thyroiditis in one case. The reason accountable
for these false positive diagnoses in our study and also in the
literature was the presence of features diagnostic of PTC even
in benign conditions of thyroid. There is evidence in the liter-
ature that the characteristic features of PTC like nuclear
grooves, nuclear pseudo-inclusions and many more features
can be seen in benign conditions of thyroid like adenomatous
goiter, Hashimoto’s thyroiditis, nodular goiter, follicular neo-
plasm, etc [18,47]. However, studies have stated that occur-
rence of these features in benign lesions is very less as
compared to PTC [48]. Hence, awareness of pathologists in
this context and strict adherence to adequacy criterion can
reduce the false positive rate.
The other six cases (out of 12 false positive cases) had a
cytological diagnosis of suspicious follicular lesion, of these
four turned out to be adenomatous goiter and two as follicular
adenoma on HPE. The diagnosis of follicular patterned lesions
can be challenging because of overlapping features between
benign and malignant lesions and is considered as a ‘gray zone’
[16,33,49].Conclusion
FNAC is a highly reliable and accurate tool to differentiate a
malignant lesion from a benign one with accuracy as high as
97%. However, certain pitfalls of FNA should be kept in mind
while reporting. The most common false negative diagnosis
was in cases with follicular pattern which constitute a ‘gray
zone’. Diagnosis of FVPTC requires meticulous examination
of smears in order to identify the nuclear features. Follicular
neoplasms i.e. follicular adenoma and carcinoma cannot be
distinguished on FNA and excision is mandatory for a deﬁnite
diagnosis, which should be indicated in FNA report. Cystic
lesions of thyroid should undergo surgical excision or close fol-
low up as these can harbor PTC, which can be missed as FNA
smears may not be representative. Owing to their small size
152 C. Sharmapapillary microcarcinomas also can get missed in FNA. The
commonest reason for false positive diagnosis is the occurrence
of nuclear features characteristic of PTC in other thyroid
lesions like nodular goiter, Hashimoto’s thyroiditis, follicular
neoplasms, etc. However, occurrence of these features in
benign lesions is very less as compared to PTC and a patholo-
gist should be aware of this fact. Nevertheless, as FNA is con-
sidered a screening procedure, particular attention should be
given to minimizing false-negative diagnoses.Conﬂict of interest
We have no conﬂict of interest to declare.
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